THE PLACE OF ANALGOSEDATION IN THE MANAGEMENT OF ACUTE ARTERIAL HYPERTENSION IN PATIENT WITH INTRACEREBRAL HEMORRHAGE (REFERENCES)
DOI:
https://doi.org/10.34287/MMT.4(55).2022.11Abstract
The aim of the study. Highlight the most well-founded knowledge that reflects the dependence of treatment and sedation options for patients in the treatment of intracerebral hemorrhage (ICH).
Materials and methods. Literature sources related to the study of the annual number of registered stroke cases in the world were analyzed. The vast majority of patients remain permanently disabled, which leads to a decrease in the able-bodied population. An important factor in the development of complications and increased mortality is the high variability and persistent increase in blood pressure (BP). Traditional tactics have a number of disadvantages. At present, there are no clear recommendations for the use of certain antihypertensive drugs, and the optimal numbers to which BP should be lowered are debatable.
The results. It has been established that sedation plays an important role in the treatment of intracerebral hemorrhage. In fact, it helps control pain, anxiety, agitation and synchronicity of the patient with the ventilator, and also reduces cerebral metabolic demands and improves the brain's tolerance to secondary damage. However, combinations of drugs for its implementation may differ even in units of the same hospital.
Conclusions. Combination therapy of propofol with opioids or dexmedetomidine with opioids is most common. However, the heterogeneity of the data makes it impossible to qualitatively interpret the obtained results. In turn, due to the uncertainty of the unequivocal tactics of analgosedation, the question of the optimal dosage of drugs is open. Thus, the optimal treatment of acute hypertension in patients with VMC remains a therapeutic dilemma and an important part of scientific research. Adequate correction of the variability of systemic hemodynamics and cerebral perfusion with the help of analgosedation is a promising direction in the treatment of ICH.
References
Sabadash E. Poluchitsya li v blizhajshee vremya ostanovit pagubnoe rasprostranenie insulta? (ukr). https://health-ua.com/article/19312-poluchitsya-li-v-blizhajshee-vremya-priostanovit-pagubnoe-rasprostranenie-i. Pereglyanuto 20 listopada, 2022.
Kush KO, Kligunenko OM. Vpliv nejrometabolichnoyi terapiyi na riven nejronspecifichnoyi enolazi ta kognitivnij status u hvorih v gostromu periodi ishemichnogo insultu. Medicina neotlozhnyh sostoyanij. 2018; 6 (93): 77-82.
Coull AJ. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organization of services. BMJ. 2004; 328: 326. Available from: doi:10.1136/bmj.37991.635266.44
Nakaz MOZ Ukrayini vid 14.02.2012 № 110 «Pro zatverdzhennya form pervinnoyi oblikovoyi dokumentaciyi ta instrukcij shodo yih zapovnennya, sho vikoristovuyutsya u zakladah ohoroni zdorov'ya nezalezhno vid formi vlasnosti ta pidporyadkuvannya». https://zakon.rada.gov.ua/laws/show/z0661-12#Text. Pereglyanuto 20 listopada, 2022.
Unifikovanij klinichnij protokol ekstrenoyi, pervinnoyi, vtorinnoyi (specializovanoyi) ta tretinnoyi (visokospecializovannoyi) medichnoyi dopomogi ta medichnoyi reabilitaciyi «Gemoragichnij insult» Ministerstva ohoroni zdorov’ya Ukrayini vid 17.04.2014. № 275. S.10-11, 33-37.
Nakaz Ministerstva ohoroni zdorov’ya Ukrayini vid 05.01.2022 № 9 «Nadannya dopomogi pri spontannomu vnutrishnomozkovomu krovovilivi». 53 s.
Ziai WC, Carhuapoma RJ. Intracerebral Hemorrhage. CONTINUUM: Lifelong Learning in Neurology [Internet]. 2018;24(6):1603-1622. Available from: doi:10.1212/con.0000000000000672.
Falcone GJ, Selim M, Brown DL, Silliman SL, Worrall BB, Meschia JF, et al. Burden of Risk Alleles for Hypertension Increases Risk of Intracerebral Hemorrhage. Stroke [Internet]. 2012;43(11):2877-2883. Available from: doi:10.1161/strokeaha.112.659755.
Garg R, Biller J. Recent advances in spontaneous intracerebral hemorrhage. F1000Research [Internet]. 2019;8:302. Available from: doi:10.12688/f1000research.16357.1.
Qureshi AI, Ezzeddine MA, Nasar A, Suri MK, Kirmani JF, Hussein HM, et al. Prevalence of elevated blood pressure in 563704 adult patients with stroke presenting to the ED in the United States. The American Journal of Emergency Medicine [Internet]. 2007;25(1):32-38. Available from: doi:10.1016/j.ajem.2006.07.008.
Zhang Y, Reilly KH, Tong W, Xu T, Chen J, Bazzano LA, et al. Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. Journal of Hypertension [Internet]. 2008;26(7):1446-1452. Available from: doi:10.1097/hjh.0b013e328300a24a.
Rodriguez-Luna D, Piñeiro S, Rubiera M, Ribo M, Coscojuela P, Pagola J. Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage. European Journal of Neurology [Internet]. 2013;20(9):1277-1283. Available from: doi:10.1111/ene.12180.
Sakamoto Y, Nagatsuka K, Tanaka E, Kobayashi J, Sato S, Arihiro S, et al. Systolic Blood Pressure After Intravenous Antihypertensive Treatment and Clinical Outcomes in Hyperacute Intracerebral Hemorrhage. Stroke [Internet]. 2013;44(7):1846-1851. Available from: doi:10.1161/strokeaha.113.001212.
Delcourt C, Huang Y, Wang J, Heeley E, Lindley R, Stapf C, et al. The Second (Main) Phase of an Open, Randomised, Multicentre Study to Investigate the Effectiveness of an Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (Interact2). International Journal of Stroke [Internet]. 2010;5(2):110-116. Available from: doi:10.1111/j.1747-4949.2010.00415.x.
Steiner T, Salman R, Beer R, Christensen H, Cordonnier C, Csibaet L et al. European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage. International Journal of Stroke. 2014;9(7): 840-855. PMID:25156220. DOI: 10.1111/ijs.12309
Hemphill CJ, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage. Stroke [Internet]. 2015;46(7):2032-2060. Available from: doi:10.1161/str.0000000000000069.
Qureshi AI, Palesch YY, Barsan WG, Hanley DF , Hsu CY, Martin RL et al.: Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. N. Engl. J. Med. 2016; 375(11): 1033–43. PMID: 27276234 PMCID: PMC5345109 DOI: 10.1056/NEJMoa1603460
Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C et al.: Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage.N. Engl. J. Med. 2013; 368(25): 2355–65. DOI:10.1056/NEJMoa1214609
Boulouis G, Morotti A, Goldstein JN, Charidimou A. Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and metaanalysis of randomised trials. J. Neurol. Neurosurg. Psychiatry. 2017; 88: 339–45. PMID:28214798 DOI: 10.1136/jnnp-2016-315346
Moullaali TJ, Wang X, Martin RH, Shipes VB, Robinson TG, Chalmes J et al. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. Lancet Neurol. 2019; 18: 857-864. PMID:31397290 Doi: 10.1016/S1474-4422(19)30196-6
Divani AA, Liu X, Di Napoli M, Lattanzi S, Ziai W, James ML et al. Blood Pressure Variability Predicts Poor In-Hospital Outcome in Spontaneous Intracerebral Hemorrhage. Stroke. 2019; 50: 2023-2029. DOI: 10/1161/STROKETAHA.119.025514
Chung PW, Kim JT, Sanossian N, Starkman S, Yamilton S, Gornbein J et al. Association Between Hyperacute Stage Blood Pressure Variability and Outcome in Patients With Spontaneous Intracerebral Hemorrhage. Stroke. 2018; 49: 348-354. PMID: 29301973 DOI:10.1161/STROKEAHA.117.01774
Anderson CS, Huang Y, Wang JG, Arima H, Yeal B, Peng B et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008; 7: 391-399. PMID: 18396107 DOI: 10.1016/S14-74442(08) 70069-3
Oddo M, Steiner LA. Sedation and analgesia in the neurocritical care unit. In: Smith M, Kofke WA, Citerio G, editors. Oxford textbook of neurocritical care. Oxford: Oxford University Press. 2016, рр. 65-77.
Ziliene V. Antihypertensive management in acute cerebral stroke. Medicina (Kaunas). 2005; 41: 81–88. PMID:15687755
Hou D, Liu, B, Zhang, J, Wang Q, Zheng W et al. Evaluation of the efficacy and safety of short-course deep sedation therapy for the treatment of intracerebral hemorrhage after surgery: a non-randomized control study. Med. Sci. Monit. 2016; 22: 2670–2678. PMID: 2746863 PMCID: PMC4975571 DOI:10.12659/msm.899787
Hernández-Durán S, Salfelder C, Schaeper J, Moerer O, Rohde V, Mielke D et al. Mechanical Ventilation, Sedation and Neuromonitoring of Patients with Aneurysmal Subarachnoid Hemorrhage in Germany: Results of a Nationwide Survey. Neurocritical Care. 2021; 34: 236–247. PMID:32583194 DOI: 10/1007/s12028-020-01029-8
Mehta S, Burry L, Cook D, Fergusson D, Steinberg M, Granton J, et al. Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. JAMA. 2012; 308: 1985–92. PMID: 23180503 DOI: 10.1001/jama.2012.13872
Strom T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet. 2010; Feb 6;375 (9713): 475–80. PMID:20116842/S0140-6736(09)62072-9
Aksay, SS, Bumb, JM, Remennik, D, Thiel M, Kranaster L, Sartorius A, et al. Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia. Neuropsychiatr. Dis. Treat. 2017; 13: 1389–1394. PMID:28579785 DOI: 10.2147/NDT.S134751
Song HL, Zhang SB. Therapeutic effect of dexmedetomidine on intracerebral hemorrhage via regulating NLRP3. Eur. Rev. Med. Pharmacol. Sci. 2019, 23(6): 2612-2619. PMID: 30964190 DOI: 10.26355/eurrev_201903_17411
Zhao J, Zhou C. The protective and hemodynamic effects of dexmedetomidine on hypertensive cerebral hemorrhage patients in the perioperative period. Exp. Ther. Med. 2016; 12: 2903–2908. PMID:27882094/etm.2016.3711
Srivastava VK, Agrawal S, Kumar S, Mishra A, Sharma S, Kumar R. Comparison of dexmedetomidine, propofol and midazolam for short-term sedation in postoperatively mechanically ventilated neurosurgical patients. J. Clin. Diagn. Res. 2014; 8: GC04-7. PMID:25386451 DOI: 10.7860/JCDR/2014/8797.4817
Wang Z, Zhou W, Dong, H, Ma X, and He Z. Dexmedetomidine pretreatment inhibits cerebral ischemia/reperfusion-induced neuroinflammation via activation of AMPK. Mol. Med. Rep. 2018; 18 (4): 3957–3964. PMID:30106098 DOI:10.3892/mmr.2018.9349
Liu H., Busl KM, and Doré S. Role of dexmedetomidine in aneurysmal subarachnoid hemorrhage: A comprehensive scoping review. J. Neurosurg. Anesthesiol. 2022; 34 (2): 176–182. PMID:33060552 DOI: 10.1097/ANA.0000000000000728
Endesfelder S, Makki H, Von Haefen C, Spies C, Bucher C, Siringer M. Neuroprotective effects of dexmedetomidine against hyperoxia-induced injury in the developing rat brain. PloS. One. 2017; 12: e0171498. DOI: 10.1371/jornal.pone.0171498
Wang Y, Han R, Zuo Z. Dexmedetomidine-induced neuroprotection: is it translational? Transl. Perioper. Pain. Med. 2016; 1: 15–19. PMID:28217717 PMCID:PMC5310645
Gong W, Zhang S, Li X, Shi L. Dexmedetomidine is superior to midazolam for sedation and cerebral protection in postoperative hypertensive intracerebral hemorrhage patients: a retrospective study. J Int Med Res. 2020, Sep; 48(9). PMID:32967514 DOI: 10.1177/0300060520957554.
Jiang L, Hu M, Lu Y, Cao X, Chang Y, Dai Z. The protective effects of dexmedetomidine on ischemic brain injury: a meta-analysis. J. Clin. Anesth. 2017; 40: 25–32. PMID:28625441 DOI:10.1016/j.jclinane.2017.04.003
Instrukciya dlya medichnogo zastosuvannya likarskogo zasobu “Propofol”. https://likicontrol.com.ua [33860]. Accessed March 15, 2022.
Shi S, Zhang H, Wang C, Yang W, Liang R, Chen Y et al. Propofol Attenuates Early Brain Injury After Subarachnoid Hemorrhage in Rats. Journal of Molecular Neuroscience. 2015; 57: 538–545.PMID:26342279 DOI:10/1007/s12031-015-0634-2
James ML, Olson DM, Graffagnino C. A pilot study of cerebral and haemodynamic physiological changes during sedation with dexmedetomidine or propofol in patients with acute brain injury. Anaesth. Intensive Care. 2012; 40(6): 949-57.PMID:23194203 DOI: 10.1177/0310057X1204000605
Steiner LA, Johnston AJ, Chatfield DA, Czosnyka M, Coleman MR, Coles JP et al. The effects of large-dose propofol on cerebrovascular pressure autoregulation in head-injured patients. Anesth. Analg. 2003; 97: 572–576. PMID:12873955 DOI: 10/1213/01.ANE.0000070234.B0
Johnston AJ, Steiner LA, Chatfield DA, Coleman MR, Coles JP, Al-Rawi PG et al. Effects of propofol on cerebral oxygenation and metabolism after head injury. Br. J. Anaesth. 2003; 91: 781–786.PMID: 14633744 DOI: 10.1093bja/aeg 256
Pinaud M, Lelausque JN, Chetanneau A, Fauchoux N, Ménégalli D, and Souron R. Effects of propofol on cerebral hemodynamics and metabolism in patients with brain trauma. Anesthesiology. 1990; 73: 404–409. PMID:2118315 DOI: 10.1097/00000542-199009000-00007
Lee JH, Kelly DF, Oertel M, McArthur DL, Glenn T.C, Vespa P, et al.Carbon dioxide reactivity, pressure autoregulation, and metabolic suppression reactivity after head injury: a transcranial Doppler study.J. Neurosurg. 2001; 95: 222–232. PMID:11780891 DOI:10.3171/jns.2001.95.2.0222
Tanguy M, Seguin P, Laviolle B, Bleichner J-P, Morandi X, and Malledant Y. Cerebral microdialysis effects of propofol versus midazolam in severe traumatic brain injury. J. Neurotrauma. 2012; 29: 1105–1110.PMID:22182405 DOI:10.1089./neu.2011.1817
James ML, Olson DM, and Graffagnino C. A pilot study of cerebral and haemodynamic physiological changes during sedation with dexmedetomidine or propofol in patients with acute brain injury. Anaesth. Intensive Care. 2012; 40: 949–957. PMID:23194203 DOI: 10.1177/0310057X1204000605
Oddo M, Crippa JA, Mehta S, Menon D, Payen JF, Taccone FS et al. Citerio. Optimizing sedation in patients with acute brain injury. Critical Care. 2016; 20(1): 128. PMID:27145814 DOI: 10.1186/s13054-016-1294-5
Johnston AJ, Steiner LA, Chatfield DA, Coleman MR, Coles JP, Al-Rawi PG et al. Effects of propofol on cerebral oxygenation and metabolism after head injury. Br. J. Anaesth. 2003; 91: 781–6. PMID:14633744 DOI:10.1093/bja/aeg256
Adembri C, Venturi L, Pellegrini-Giampietro DE. Neuroprotective effects of propofol in acute cerebral injury. CNS Drug. Rev. 2007; 13: 333–51. PMID: 17894649 DOI:10.1111/j.1527-3458.2007.00015.x
Hutchens MP, Memtsoudis S, Sadovnikoff N. Propofol for sedation in neuro-intensive care. Neurocrit. Care. 2006; 4: 54–62. PMID:16498196 DOI:10.1385/NCC:4:054
Nguyen T, Pope K, Capobianco P, Cao-Pham M, Hassan S, Kole MJ et al. Sedation patterns and hyperosmolar therapy in emergency departments were associated with blood pressure variability and outcomes in patients with spontaneous intracranial hemorrhage. J Emerg Trauma Shock, 2020;13:151-60. PMID:33013096 DOI:10.4103/JETS.JETS._76_19
Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF,et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the Intensive Care Unit: executive summary. Am J. Health Syst. Pharm. 2013;70:53-8. PMID:23269131 DOI: 10.1097/CCM.0b013e.3182783b72
Bauer TM, Ritz R, Haberthur C, Ha HR, Hunkeler W, Sleight AJ, et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet. 1995; 346: 145–7. PMID:7603229 DOI: 10.1016/s0140-6736(95)91209-6
Brummel NE, Girard TD. Preventing delirium in the intensive care unit. Crit. Care Clin. 2013; 29: 51–65. PMID:23182527 DOI:10.1016/j.ccc.2012.10.007
White PF, Way WL, Trevor AJ. Ketamine - its pharmacology and therapeutic uses. Anesthesiology. 1982; 56: 119–36. PMID: 6892475 DOI: 10.1097/00000542-198202000-00007
Zeiler FA, Teitelbaum J, West M, Gillman LM. The ketamine effect on intracranial pressure in nontraumatic neurological illness. J. Crit. Care. 2014; 29: 1096–106. PMID:249966763 DOI:10.1016/j.jcrc.2014.05.024
Bourgoin A, Albanese J, Wereszczynski N, Charbit M, Vialet R, Martin C. Safety of sedation with ketamine in severe head injury patients: comparison with sufentanil. Crit Care Med. 2003; 31: 711–7. PMID:12626974 DOI:10.1097/01.CCN.0000044505.24727.16
Himmelseher S, Durieux ME. Revising a dogma: ketamine for patients with neurological injury? Anesth. Analg. 2005; 101: 524–34. DOI:10.1213/01.ANE.0000160585.43587.5B
Karabinis A, Mandragos K, Stergiopoulos S, Komnos A, Soukup J, Speelberg B et al. Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]. Crit. Care. 2004; 8: R268–80. PMID:1531228 DOI;10.1186/cc2896
